Bayer is said to be facing a comparison in the glyphosate process. This is reported by the “Bloomberg” news agency. The deal is expected to be worth $ 10 billion. Bayer refuses to comment on this. So nothing is confirmed yet.
An agreement at this level meets the expectations of DZ Bank analysts. In their model, however, they had included a discount of 20 billion euros. This is how you want to avoid negative surprises. An agreement at the lower level would raise the target price by around EUR 10.
The analysts stick to the buy recommendation for Bayer shares. The experts continue to see the target price at EUR 75.00.
According to rumors, the experts at Baader also confirm their recommendation to buy Bayer papers. You see the target price at 105.00 euros.
Up to 85,000 cases could be terminated. There are currently 125,000 glyphosate cages against Bayer in the United States. An agreement would give the course clear impetus from the analysts’ perspective.
Bayer shares gained 6.2 percent in the morning to EUR 61.25.